Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall Street - shutterstock_1321462394
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks Barchart - Tue May 14, 4:33AM CDT

June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
INCY : 65.87 (+0.76%)
INTC : 32.98 (-5.42%)
SQSP : 43.84 (+0.05%)
AMAT : 210.26 (-3.40%)
HD : 363.36 (-0.74%)
ALC.Z.IX : 80.760 (+1.03%)
DHER.D.DX : 19.500 (-0.13%)
RHM.D.DX : 493.700 (+0.69%)
FULC : 8.00 (-1.48%)
FOLD : 10.38 (-2.54%)
Amicus Therapeutics: Q1 Earnings Snapshot AP - Thu May 9, 6:21AM CDT

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 10.38 (-2.54%)
Charts, tickers, traders - iStock-884650780
2 ‘Strong-Buy’-Rated Stocks With Around 50% Upside Barchart - Thu Jan 18, 9:13AM CST

Wall Street predicts that these rapidly expanding growth stocks will generate outsized gains this year.

$SPX : 5,505.00 (-0.71%)
$NASX : 17,726.94 (-0.81%)
CVE : 19.92 (-1.39%)
FOLD : 10.38 (-2.54%)
NGG24 : 2.490s (-8.19%)
Amicus Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 10.38 (-2.54%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease PR Newswire - Sun Oct 1, 2023

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 10.38 (-2.54%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023 Associated Press - Fri Sep 29, 2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.4900 (-1.97%)
MTN : 180.26 (+0.37%)
FOLD : 10.38 (-2.54%)
BLK : 830.70 (+0.21%)
NKE : 72.70 (+0.44%)
WuXi Biologics Reports Solid 2023 Interim Results PR Newswire - Wed Aug 23, 2023

Revenue Increased by 17.8% Y-o-Y to RMB8,492.0 Million Adjusted Net Profit Rose by 0.4% to RMB2,925.6 Million Non-COVID Revenue Achieved 59.7% Y-o-Y Growth,...

FOLD : 10.38 (-2.54%)
Amicus Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 10.38 (-2.54%)
Amicus Therapeutics: Q1 Earnings Snapshot AP - Wed May 10, 2023

Amicus Therapeutics: Q1 Earnings Snapshot

FOLD : 10.38 (-2.54%)
WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease PR Newswire - Tue Mar 28, 2023

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 10.38 (-2.54%)

Barchart Exclusives

Stocks Set to Open Higher After Biden’s Withdrawal, Earnings and Key U.S. Inflation Data in Focus Barchart - 31 minutes ago
September S&P 500 E-Mini futures (ESU24) are up +0.47%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.59% this morning as investors looked past Joe Biden’s exit from his presidential reelection campaign and awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” companies Tesla and Alphabet, as well as the release of the Fed’s preferred inflation gauge later in the week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot